LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)

Clinical trial NCT04446962 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04446962
Sponsor: Institut Curie
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoma, Large B-Cell, Diffuse Central Nervous System Neoplasms, Primary

Start date: 2020-10-30
Primary completion: 2035-02-02
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.